Related Experiment Video
Updated: Dec 12, 2025

07:23
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
940
Long Non-Coding RNAs in Drug Resistance of Breast Cancer
Tonghua Du1, Ying Shi1, Shengnan Xu1
1Department of Breast Surgery, The Second Hospital of Jilin University, Changchun, Jilin, People's Republic of China.
Oncotargets and Therapy
|August 9, 2020
Summary
Long non-coding RNAs (lncRNAs) drive breast cancer drug resistance through complex mechanisms. Targeting these lncRNAs offers a promising strategy to overcome treatment failure in breast cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Breast cancer (BC) remains a leading cause of cancer death in women.
- Therapeutic advancements have improved outcomes, but drug resistance limits efficacy.
- Long non-coding RNAs (lncRNAs) play a critical role in BC progression and treatment resistance.
Purpose of the Study:
- To review current knowledge on lncRNA mechanisms in BC drug resistance.
- To explore the clinical potential of lncRNAs as therapeutic targets for overcoming BC resistance.
Main Methods:
- Literature review of recent studies on lncRNAs and BC drug resistance.
- Analysis of molecular mechanisms by which lncRNAs modulate drug resistance.
- Discussion of emerging therapeutic strategies targeting lncRNAs in BC.
Main Results:
- lncRNAs contribute to BC drug resistance through diverse molecular pathways.
- Specific lncRNAs have been identified as key regulators of resistance to various therapies.
- lncRNAs are implicated in chemoresistance, endocrine resistance, and targeted therapy resistance.
Conclusions:
- lncRNAs are crucial mediators of drug resistance in breast cancer.
- Targeting lncRNAs presents a novel therapeutic avenue to improve treatment outcomes for BC patients.
- Further research into lncRNA functions can pave the way for personalized medicine approaches in BC treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
9.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
lncRNA - Long Non-coding RNAs
3.2K
3.2K
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Types of RNA
8.6K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
8.6K
Types of RNA
72.0K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.0K
MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
